-transparent.png){kind=logo}
alpha-Helical CRF-(9-41) is an analogue of corticotropin-releasing factor (CRF) that antagonizes CRF-stimulated ACTH release in rats. In the present study, alpha-helical CRF-(9-41) was tested to determine whether it would antagonize the ACTH-releasing activity of CRF or urotensin I (UI) observed with superfused, dispersed goldfish anterior pituitary cells. At a concentration of 4 microM, alpha-helical CRF-(9-41) completely blocked the ACTH-releasing activity of 100 nM CRF or 100 nM UI. The inhibitor by itself showed little intrinsic ACTH-releasing activity. This investigation reveals similarities in the CRF-antagonism of alpha-helical CRF-(9-41) in the teleost and mammalian pituitary in vitro. It also provides are similar and suggests that alpha-helical CRF-(9-41) may be useful as a tool to investigate the effects of CRF-like and UI-like peptides in teleost fishes.
M M Weld, and
J N Fryer, and
J Rivier, and
K Lederis
December 1983,
Endocrinology,
M M Weld, and
J N Fryer, and
J Rivier, and
K Lederis
April 1997,
Behavioral neuroscience,
M M Weld, and
J N Fryer, and
J Rivier, and
K Lederis
January 1984,
Peptides,
M M Weld, and
J N Fryer, and
J Rivier, and
K Lederis
April 1989,
Journal of neuroendocrinology,
M M Weld, and
J N Fryer, and
J Rivier, and
K Lederis
April 1993,
Bollettino della Societa italiana di biologia sperimentale,
M M Weld, and
J N Fryer, and
J Rivier, and
K Lederis
June 1990,
General and comparative endocrinology,
M M Weld, and
J N Fryer, and
J Rivier, and
K Lederis
November 1983,
Life sciences,
M M Weld, and
J N Fryer, and
J Rivier, and
K Lederis
December 1989,
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
M M Weld, and
J N Fryer, and
J Rivier, and
K Lederis
August 2009,
Neuropharmacology,
M M Weld, and
J N Fryer, and
J Rivier, and
K Lederis
January 1993,
Brain research bulletin,
